[MO/URSA-QUALITY] URSA-QUALITY-SPC2: Statin Therapy for ASCVD Patients (SPC2)
  • 18 Jul 2025
  • 1 Minute to read
  • Dark
    Light

[MO/URSA-QUALITY] URSA-QUALITY-SPC2: Statin Therapy for ASCVD Patients (SPC2)

  • Dark
    Light

Article summary

Object Description

Among patients with atherosclerotic cardiovascular disease, the percentage who remained on a high-intensity or moderate-intensity statin medication for at least 80% of the treatment period in the last 12 months. Unadjusted Certified Measure da88ce42-9d33-4fe2-a7ca-de989d786bb1

Metadata

  • Table Name: ursa.mo_ursa_quality_spc2
  • Layer: MEASURE_OBJECT
  • Object Type: Measure Object
  • Temporal Class: Event
  • Case ID: Patient ID, Output NCQA Payer Type Code, Snapshot Date
  • Event Date: Snapshot Date
  • Primary Key: Ursa Serial ID

Published Fields

  • Measure Fields

    • Denominator
    • Numerator
  • [No Field Group]

    • Ursa Serial ID

Was this article helpful?